India: market value of leading fastest growing molecules in the cardiac segment 2020

Ticagrelor was the leading fastest growing molecule in the cardiac segment in the Indian pharmaceutical market with a market value of over three billion Indian rupees in financial year 2020. JB Chemicals, Lupin and Cadila companies had a strong presence in top ten fastest growing molecules that year.

Market value of leading fastest growing molecules in the cardiac segment across India in financial year 2020 (in billion Indian rupees)

Characteristic	Market value in billion Indian rupees
Ticagrelor	3.24
Aspirin + Rosuvastatin + Clopidogrel	2.85
Cilnidipine + Telmisartan	1.89
Rosuvastatin + Clopidogrel	1.36
Dabigatran	1.22
Rivaroxaban	1.01
Saroglitazar	0.97
Apixaban	0.71
Telmisartan + Cilnidipine + Chlorthalidone	0.69
Olmesartan + Cilnidipine + Chlorthalidone	0.61

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

September 2020

More information

Region

India

Survey time period

FY 2020

Special properties

molecules above 50 million Indian rupees in size.

Supplementary notes

India's financial year begins in April and ends in March. For example, FY 2020 started in April 2019 and ended in March 2020.

One Indian rupee is equal to 0.011 euros and 0.014 U.S. dollars as of January 2021.

Values have been rounded for clarity.

Citation formats